We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $320M
1-Year Est. Return 140.1%
This Fund
S&P 500
This Quarter Est. Return
+6.01%
1 Year Est. Return
+140.1%
3 Year Est. Return
+250.82%
5 Year Est. Return
+197.91%
10 Year Est. Return
+3,970.08%
AUM
$133M
AUM Growth
–
Cap. Flow
+$130M
Cap. Flow %
97.44%
Top 10 Hldgs %
71.03%
Holding
57
New
57
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
TARO
Taro Pharmaceutical Industries Ltd.
TARO
+$15.7M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$14.3M
3
TSLA icon
Tesla
TSLA
+$12.9M
4
AGN
Allergan plc
AGN
+$8.63M
5
BX icon
Blackstone
BX
+$8.48M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 75.91%
2 Consumer Discretionary 14.07%
3 Financials 6.75%
4 Miscellaneous 2.84%
5 Communication Services 0.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TARO
1
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$15.8M 11.89%
+106,931
New +$15.7M
REGN icon
2
Regeneron Pharmaceuticals
REGN
$80.5B
$14.9M 11.2%
+36,355
New +$14.3M
TSLA icon
3
Tesla
TSLA
$1.44T
$12.3M 9.21%
+827,175
New +$12.9M
BX icon
4
Blackstone
BX
$96.5B
$8.99M 6.75%
+270,911
New +$8.48M
AGN
5
DELISTED
Allergan plc
AGN
$8.89M 6.67%
+34,526
New +$8.63M
AVDL
6
DELISTED
Avadel Pharmaceuticals
AVDL
$8.48M 6.37%
+495,154
New +$7.07M
INSY
7
DELISTED
Insys Therapeutics, Inc.
INSY
$8.05M 6.05%
+382,054
New +$7.55M
HZNP
8
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$7.49M 5.62%
+580,684
New +$7.27M
LCI
9
DELISTED
Lannett Company, Inc.
LCI
$5.02M 3.77%
+29,248
New +$5.43M
JAZZ icon
10
Jazz Pharmaceuticals
JAZZ
$16B
$4.68M 3.52%
+28,617
New +$4.75M
ALXN
11
DELISTED
Alexion Pharmaceuticals
ALXN
$4.48M 3.36%
+24,208
New +$4.49M
PRGO icon
12
Perrigo
PRGO
$1.9B
$4.21M 3.16%
+25,165
New +$3.94M
SGNT
13
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$2.6M 1.95%
+103,483
New +$3.04M
JNP
14
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$2.27M 1.7%
+405,356
New +$2.36M
BWLD
15
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$2.25M 1.69%
+12,497
New +$1.94M
AKRX
16
DELISTED
Akorn Inc
AKRX
$1.83M 1.37%
+50,515
New +$1.95M
LGND icon
17
Ligand Pharmaceuticals
LGND
$5.67B
$1.74M 1.31%
+52,461
New +$1.71M
AMZN icon
18
Amazon
AMZN
$2.77T
$1.6M 1.2%
+103,420
New +$1.61M
EGRX
19
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.58M 1.18%
+101,823
New +$1.3M
CMG icon
20
Chipotle Mexican Grill
CMG
$45.8B
$1.4M 1.05%
+102,300
New +$1.34M
BIIB icon
21
Biogen
BIIB
$32.1B
$1.31M 0.99%
+3,869
New +$1.25M
ANIP icon
22
ANI Pharmaceuticals
ANIP
$1.61B
$1.27M 0.95%
+22,524
New +$993K
MNK
23
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$1.09M 0.82%
+10,964
New +$1.01M
PTX
24
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$1.05M 0.79%
+11,216
New +$1.07M
SLXP
25
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$1.04M 0.78%
+9,040
New +$1.1M
1
2 3

Similar funds

PCM
Passive Capital Management Baltimore, Maryland $320M AUM 17.24% 1-Year Est. Return
IP
Investment Partners New Philadelphia, Ohio $320M AUM 27.59% 1-Year Est. Return
PCM
Prospera Capital Management Gilbert, Arizona $320M AUM 19.55% 1-Year Est. Return
LJCM
Lee Johnson Capital Management Fort Worth, Texas $320M AUM 60.02% 1-Year Est. Return
GTAM
Global Trust Asset Management West Palm Beach, Florida $320M AUM 83.68% 1-Year Est. Return
SIC
Samalin Investment Counsel Chappaqua, New York $320M AUM 20.87% 1-Year Est. Return
AFS
Aft Forsyth & Sober Valrico, Florida $320M AUM 26.86% 1-Year Est. Return
BMCM
Burns Matteson Capital Management Corning, New York $320M AUM 71.11% 1-Year Est. Return

JW Asset Management's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for JW Asset Management, which disclosed 57 positions worth $133M. Its ten largest holdings account for 71% of the portfolio.

Its largest position is Taro Pharmaceutical Industries Ltd.: 106,931 shares worth $15.8M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, followed by Consumer Discretionary and Financials.

  • JW Asset Management's largest Q4 2014 buy was Taro Pharmaceutical Industries Ltd.: 106,931 shares worth $15.8M.
  • JW Asset Management's ten largest holdings make up 71% of its $133M portfolio in Q4 2014.
  • JW Asset Management disclosed 57 positions in Q4 2014, its first 13F filing on record.

Based on JW Asset Management's 13F filing for Q4 2014, filed 5 Feb 2015.